Author + information
- Received February 22, 2010
- Accepted March 11, 2010
- Published online July 1, 2010.
- Amish C. Sura, MD⁎ ( and )
- John S. Douglas Jr, MD
- ↵⁎Reprint requests and correspondence:
Dr. Amish C. Sura, Andreas Gruentzig Cardiovascular Center, Emory University Hospital, Suite F606, 1364 Clifton Road, Atlanta, Georgia 30322
A 78-year-old man was referred to our institution for treatment of an unusual expanding aneurysm. There was a history of prior coronary artery bypass surgery in 1999. Subsequently, he had developed exertional dyspnea, and chest X-rays demonstrated a right chest mass that was increasing in size. Multislice computed tomography revealed a partially thrombosed 16.5 × 6.5 cm aneurysm arising from the site of the saphenous vein conduit to the right coronary artery and extending in the distribution of this graft, suggesting a true saphenous vein graft aneurysm (Figs. 1A and Fig. 1B). This aneurysm impinged on the diaphragm, compressed the liver inferiorly, and did not communicate with the distal right coronary artery.
Due to the expanding aneurysm and potential for rupture, closure was recommended. A surgical approach was judged possible but required repeat sternotomy and use of cardiopulmonary bypass. Percutaneous closure was judged to be feasible and much less invasive and was elected by the patient.
From a femoral approach, a 7-F JR4 guide catheter (Medtronic, Inc., Minneapolis, Minnesota) was used to engage the neck of the aneurysm. Angiography was performed (Fig. 2A) and a 5 × 20 mm balloon was used to “size” the neck at approximately 3 mm in diameter (Fig. 2B). A stiff guidewire was introduced (Fig. 2C) over which a 9-F Amplatzer delivery sheath was cannulated into the neck of the aneurysm. A 4-mm Amplatzer Septal occluder device (AGA Medical, Golden Valley, Minnesota) was deployed (Fig. 2D), occluding the aneurysm neck. Aortic angiography and transesophageal echocardiography confirmed the absence of flow into or out of the aneurismal cavity (Fig. 2E).
The patient was discharged the following day on aspirin and clopidogrel (75 mg). At 3 months post-procedure, the patient was asymptomatic and fully active.
Aortocoronary saphenous vein graft aneurysms are a rare complication of coronary artery bypass graft surgery. The incidence is unknown but may be increasing with increasing use of advanced imaging techniques (1–3). They often present as a mediastinal mass. Symptoms can be nonspecific and include dyspnea, chest discomfort, and hemoptysis. Rupture is associated with a high mortality rate. They are usually treated surgically, although secondary thrombosis due to coil deployment has been described (2,4).
Dr. Douglas receives grant support from Johnson & Johnson, Medtronic, Boston Scientific, and Abbott
- Received February 22, 2010.
- Accepted March 11, 2010.
- American College of Cardiology Foundation